MEP18308A - Benzothiophenes, formulations containing same, and methods - Google Patents

Benzothiophenes, formulations containing same, and methods

Info

Publication number
MEP18308A
MEP18308A MEP-183/08A MEP18308A MEP18308A ME P18308 A MEP18308 A ME P18308A ME P18308 A MEP18308 A ME P18308A ME P18308 A MEP18308 A ME P18308A
Authority
ME
Montenegro
Prior art keywords
compounds
benzothiophenes
methods
formulations containing
containing same
Prior art date
Application number
MEP-183/08A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Gordon N Arbuthnot
Brian W Dalder
Kerry J Hartauer
Wayne D Luke
Robert E Stratford Jr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP18308(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9607110.5A external-priority patent/GB9607110D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MEP18308A publication Critical patent/MEP18308A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Thin Film Transistor (AREA)
MEP-183/08A 1996-03-26 1997-03-20 Benzothiophenes, formulations containing same, and methods MEP18308A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1416796P 1996-03-26 1996-03-26
GBGB9607110.5A GB9607110D0 (en) 1996-04-04 1996-04-04 Benzothiopenes formulations containing same and methods
PCT/US1997/004259 WO1997035571A1 (en) 1996-03-26 1997-03-20 Benzothiophenes, formulations containing same, and methods
YUP41898 1998-09-25

Publications (1)

Publication Number Publication Date
MEP18308A true MEP18308A (en) 2010-06-10

Family

ID=26309061

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-183/08A MEP18308A (en) 1996-03-26 1997-03-20 Benzothiophenes, formulations containing same, and methods
MEP-2008-183A ME00074B (me) 1996-03-26 1997-03-20 Benzotiofeni, formulacije koje ih sadrže i proizvod

Family Applications After (1)

Application Number Title Priority Date Filing Date
MEP-2008-183A ME00074B (me) 1996-03-26 1997-03-20 Benzotiofeni, formulacije koje ih sadrže i proizvod

Country Status (30)

Country Link
EP (2) EP0910369B1 (pt)
JP (5) JP2000507268A (pt)
CN (1) CN1162153C (pt)
AR (1) AR006387A1 (pt)
AT (1) ATE464897T1 (pt)
AU (1) AU723797B2 (pt)
BR (1) BR9708248A (pt)
CA (1) CA2250191C (pt)
CO (1) CO4780022A1 (pt)
CZ (1) CZ300341B6 (pt)
DE (1) DE69739855D1 (pt)
DK (1) DK0910369T3 (pt)
EA (1) EA001257B1 (pt)
ES (1) ES2341399T3 (pt)
HK (1) HK1020671A1 (pt)
ID (1) ID19813A (pt)
IL (2) IL126320A (pt)
ME (2) MEP18308A (pt)
MY (1) MY115533A (pt)
NO (1) NO320894B1 (pt)
NZ (1) NZ332036A (pt)
PL (1) PL191148B1 (pt)
PT (1) PT910369E (pt)
RO (1) RO121117B1 (pt)
SI (1) SI0910369T1 (pt)
TR (1) TR199801915T2 (pt)
TW (1) TW513421B (pt)
UA (1) UA57596C2 (pt)
WO (1) WO1997035571A1 (pt)
YU (1) YU41898A (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300341B6 (cs) * 1996-03-26 2009-04-22 Eli Lilly And Company Farmaceutická kompozice obsahující raloxifen
ZA979723B (en) 1996-10-30 1999-07-29 Lilly Co Eli Methods of preventing breast cancer.
CA2219377A1 (en) * 1996-10-30 1998-04-30 Eli Lilly And Company Improvements in or relating to the prophylaxis of breast cancer
AU2003266940B2 (en) 2002-09-30 2007-02-08 A/S Gea Farmaceutisk Fabrik Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
KR20090082399A (ko) 2006-10-17 2009-07-30 씨아이피엘에이 엘티디. 벤조티오펜 화합물의 결정형 및 그의 제조방법
WO2009080364A1 (en) * 2007-12-21 2009-07-02 Synthon B.V. Raloxifene composition
PL3202420T3 (pl) * 2008-12-11 2020-07-13 Besins Healthcare Luxembourg Sarl Transdermalne kompozycje farmaceutyczne zawierające SERM
EP2448562B1 (en) 2009-07-02 2013-11-06 Synthon B.V. Raloxifene composition
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
GB201515391D0 (en) * 2015-08-28 2015-10-14 Amazentis Sa Compositions
GB201515387D0 (en) * 2015-08-28 2015-10-14 Amazentis Sa Compositions
PL3251661T3 (pl) 2016-05-30 2021-06-14 Sun Pharmaceutical Industries Limited Kompozycja raloksyfenu do posypywania

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
JPS63112519A (ja) * 1986-10-28 1988-05-17 Shin Etsu Chem Co Ltd ニフエジピン製剤の製造方法
NL9000634A (nl) * 1990-03-20 1991-10-16 Catharina Ziekenhuis Stichting Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding.
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5547683A (en) * 1992-10-09 1996-08-20 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Method for producing microgranulated particle
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US5482950A (en) * 1993-10-15 1996-01-09 Eli Lilly And Company Methods for lowering serum cholesterol
JPH09506898A (ja) * 1993-12-21 1997-07-08 イーライ・リリー・アンド・カンパニー 非ペプチドタキキニン受容体アンタゴニスト
BR9500758A (pt) * 1994-03-02 1995-10-24 Lilly Co Eli Formulaçoes farmacêuticas para administraçao oral
US5478847A (en) * 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
US6723739B1 (en) 1994-05-20 2004-04-20 Eli Lilly And Company Glucopyranoside benzothiophenes
US5494920A (en) * 1994-08-22 1996-02-27 Eli Lilly And Company Methods of inhibiting viral replication
CO4410191A1 (es) 1994-09-19 1997-01-09 Lilly Co Eli SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS
US5494929A (en) 1995-01-12 1996-02-27 Eli Lilly And Company Methods of inhibiting growth hormone effects
US5532254A (en) * 1995-06-07 1996-07-02 Eli Lilly And Company Modulation of calcium channels using benzothiophenes
CZ300341B6 (cs) * 1996-03-26 2009-04-22 Eli Lilly And Company Farmaceutická kompozice obsahující raloxifen

Also Published As

Publication number Publication date
AR006387A1 (es) 1999-08-25
SI0910369T1 (sl) 2010-08-31
NO984444L (no) 1998-11-26
CO4780022A1 (es) 1999-05-26
PT910369E (pt) 2010-06-04
YU41898A (sh) 1999-07-28
PL329051A1 (en) 1999-03-01
JP2015157865A (ja) 2015-09-03
NZ332036A (en) 1999-04-29
TR199801915T2 (xx) 1998-12-21
JP2016106159A (ja) 2016-06-16
IL126320A (en) 2001-08-08
CA2250191C (en) 2005-11-15
EP0910369B1 (en) 2010-04-21
EP2266560A1 (en) 2010-12-29
BR9708248A (pt) 1999-07-27
MY115533A (en) 2003-07-31
IL140742A (en) 2012-02-29
EA199800865A1 (ru) 1999-02-25
NO984444D0 (no) 1998-09-24
EA001257B1 (ru) 2000-12-25
ME00074B (me) 2010-10-10
IL140742A0 (en) 2002-02-10
AU2215497A (en) 1997-10-17
ATE464897T1 (de) 2010-05-15
EP0910369A4 (en) 2001-03-21
IL126320A0 (en) 1999-05-09
NO320894B1 (no) 2006-02-06
RO121117B1 (ro) 2006-12-29
UA57596C2 (uk) 2003-06-16
CA2250191A1 (en) 1997-10-02
JP2009019057A (ja) 2009-01-29
ID19813A (id) 1998-08-06
EP0910369A1 (en) 1999-04-28
JP6095725B2 (ja) 2017-03-15
DK0910369T3 (da) 2010-07-26
WO1997035571A1 (en) 1997-10-02
CN1213967A (zh) 1999-04-14
JP2000507268A (ja) 2000-06-13
PL191148B1 (pl) 2006-03-31
JP6095821B2 (ja) 2017-03-15
AU723797B2 (en) 2000-09-07
DE69739855D1 (de) 2010-06-02
ES2341399T3 (es) 2010-06-18
CZ305398A3 (cs) 1999-05-12
CZ300341B6 (cs) 2009-04-22
TW513421B (en) 2002-12-11
HK1020671A1 (en) 2000-05-19
JP2013166797A (ja) 2013-08-29
CN1162153C (zh) 2004-08-18

Similar Documents

Publication Publication Date Title
MEP18308A (en) Benzothiophenes, formulations containing same, and methods
TW240215B (pt)
FI945081A (fi) Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon
FI934274A0 (fi) N-sulfonyl-2-oxi-indolderivat, deras framstaellning och dessa innehaollande farmaceutiska kompositioner
IL97025A0 (en) 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives,their preparation and pharmaceutical compositions containing them
MY104535A (en) Oral composition for the treatment of inflammatory bowel diseases.
RS49703B (sr) Farmaceutske kompozicije koje sadrže vitamin d i kalcijum, njihovo dobijanje i upotreba
IL98262A (en) Chromone derivatives and pharmaceutical compositions containing them
ZA90966B (en) Oxidized diphenylheteroalkanes,the preparation and use thereof
YU42397A (sh) Korišćenje raloksifena za pripremu leka
AP2000001837A0 (en) Pharmaceutical compositions containing micronized bicyclic drugs.
DE3369983D1 (en) Isoquinoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use
IL93165A0 (en) Phenylhydrazones,their preparation and pharmaceutical compositions containing them
NZ212614A (en) Acetylenic phenoxypropanol derivatives and pharmaceutical compositions
IL65493A0 (en) Phenethanolamine derivatives,their preparation and pharmaceutical compositions containing them
IL66960A0 (en) 4-phenyl-quinazoline derivatives,their preparation and pharmaceutical compositions containing them
GR3015706T3 (en) Benzylselenobenzamides of aminopyridines and picolylamines.
FR2541114B1 (fr) Compositions pharmaceutiques antifongiques utilisables par voie orale contenant de l'omoconazole
IT1314204B1 (it) Complessi di rutenio con elevata attivita' antitumorale
IT1273528B (it) Agonisti del recettore a3 della adenosina e composizioni farmaceutiche che li contengono